; Global Cancer Drugs market 2009-2013
Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out
Your Federal Quarterly Tax Payments are due April 15th Get Help Now >>

Global Cancer Drugs market 2009-2013

VIEWS: 79 PAGES: 23

The cancer drugs represents a large potential therapeutic market. Cancer is the second leading cause of death worldwide, next only to cardiovascular diseases. According to World Heath Organization (WHO), 12 million cancer deaths are likely to occur worldwide, by 2030. Further, the adoption of unhealthy lifestyles such as increasing use of tobacco, alcohol, and rise in obesity rate in the underdeveloped and developing countries are important factors for the cause of this disease. Owing to the growing number of cancer-related diseases, there is an intense interest towards cancer drugs research. Many companies (pharmaceutical and biotechnology) are focusing on developing advanced cancer drugs for targeted therapy. Besides, many domestic companies have also increased their focus on R&D capabilities to develop effective cancer treatment for breast, prostate, colon, and pancreas cancers. Over the next few years, the market is set to witness launch of advanced cancer drugs and entry of new players. Thus, intensifying competition in this industry in the development and marketing of cancer drugs. The significant advancements in newer cancer drugs and benefits of effective treatment of various cancers are likely to boost this market. Also, the increasing prevalence of cancer cases and its subsequent need for effective means of treatment offer potential growth opportunity. Further, the enhanced focus on tailored drug delivery in cancer treatment coupled with benefits of molecular biomarkers in drug discovery are likely to support growth in the Cancer Drugs market. This report highlights the scope of the Global Cancer Drugs market 2009-2013, along with trends, drivers, growth inhibitors and a few major vendors in the market.

More Info
  • pg 1
									Global Cancer Drugs Market

        2009-2013
                                                                                 Global Cancer Drugs Market




                                            Table of Contents
1. Introduction...........................................................................................................3
2. Market Size and Forecast.........................................................................................4
3. Geographic Segmentation........................................................................................5
   3.1.Market Size in Americas....................................................................................6
   3.2.Market Size in EMEA.........................................................................................7
   3.3.Market Size in APAC..........................................................................................8
4. Market Trends in Cancer Drugs.................................................................................9
5. Market Drivers in Cancer Drugs..............................................................................11
6. Market Challenges in Cancer Drugs.........................................................................13
7. Vendors...............................................................................................................15
8. Related Reports in this Series.................................................................................22



                                              List of Exhibits
Exhibit 2.1: Cancer Drugs Market Size & Forecast 2009-2013 (In $billion).........................4
Exhibit 3.1: Geographic Segmentation - 2009................................................................5
Exhibit 3.2: Cancer Drugs Market Size in Americas 2009-2013 (in $billion).......................6
Exhibit 3.3: Cancer Drugs Market Size in EMEA 2009-2013 (in $billion)............................7
Exhibit 3.4: Cancer Drugs Market Size in APAC 2009-2013 (in $billion).............................8




TechNavio Insights – Book your Analyst Hour

To become a member of TechNavio TM and enjoy the many benefits of its membership, which include
one free hour of an analyst’s time for your queries on this report, please visit:
http://www.technavio.com/user/register




                                                                                                                        2
                                                            Global Cancer Drugs Market




1. Introduction

Cancer Drugs are substances used to target, destroy and control the growth of cancerous
cell; thereby, aiding in the treatment of cancer. These drugs may be used alone or in
combination with other treatments, such as surgery or radiation therapy.



The cancer drugs represents a large potential therapeutic market. Cancer is the second
leading cause of death worldwide, next only to cardiovascular diseases. According to World
Heath Organization (WHO), 12 million cancer deaths are likely to occur worldwide, by
2030. Further, the adoption of unhealthy lifestyles such as increasing use of tobacco,
alcohol, and rise in obesity rate in the underdeveloped and developing countries are
important factors for the cause of this disease.

Owing to the growing number of cancer diseases, there is an intense interest towards
cancer drugs research. Many companies (pharmaceutical and biotechnology) are focusing
on developing advanced cancer drugs for targeted therapy. Besides, many domestic
companies have also increased their focus on R&D capabilities to develop effective cancer
treatment for breast, prostate, colon, and pancreas cancers. Over the next few years, the
market is set to witness launch of advanced cancer drugs and entry of new players. Thus,
intensifying competition in this industry in the development and marketing of cancer drugs.

The significant advancements in newer cancer drugs and benefits of effective treatment of
various cancers are likely to boost this market. Also, the increasing prevalence of cancer
cases and its subsequent need for effective means of treatment offer potential growth
opportunity. Further, the enhanced focus on tailored drug delivery in cancer treatment
coupled with benefits of molecular biomarkers in drug discovery are likely to support
growth in the Cancer Drugs market.

This report highlights the scope of the Global Cancer Drugs market 2009-2013, along with
trends, drivers, growth inhibitors and a few major vendors in the market.




                                                                                         3
                                                                     Global Cancer Drugs Market




2. Market Size and Forecast
According to TechNavio, the market for Global Cancer Drugs is forecast to reach $84.5
billion in 2013 from $53.8 billion in 2009; thus, growing at a CAGR of 11.9 percent over the
period (Exhibit 2.1).


Exhibit 2.1: Cancer Drugs Market Size & Forecast 2009-2013 (In $billion)



                     90                    
								
To top